Skip to main content

Table 4 Epidemiological parameters from 1000 patients’ simulation – patients having at least 5 retrieved oocytes

From: Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF

 

HP-hMG

r-FSH + r-LH

Cycle 1 clinical pregnancies

191

284

Cycle 2 clinical pregnancies

97

128

Cycle 3 clinical pregnancies

51

60

Clinical pregnancies

339

473

Average time at clinical pregnancy (months)

13.5

13.2

Clinical pregnancy rate

17.0%

23.6%

 

HP-hMG

r-FSH + r-LH

Cycle 1 positive hCGtest

232

339

Cycle 2 positive hCG test

118

153

Cycle 3 positive hCG test

62

72

Positive hCG tests

413

563

Average time at positive hCG test (months)

7.5

7.2

Positive hCG test rate

20.6%

28.2%

 

HP-hMG

r-FSH + r-LH

Miscarriages

37

45